How interchangeable parts improve supply chain resilience

The COVID-19 pandemic highlighted both the strengths and vulnerabilities of the biopharmaceutical supply chain. While rapid vaccine development demonstrated what the industry could achieve, unprecedented demand for single-use components led to extended lead times, supply shortages and the risk of production delays. These challenges revealed the importance of building greater flexibility and resilience into biomanufacturing processes.

WMArchitect™ Interchangeable Parts is a solution to avoid supply chain disruption as it enables manufacturers to qualify alternative components during the design stage, before supply issues arise. Developed through industry collaboration within BioPhorum, the approach establishes clear guidance for identifying and categorising interchangeable components, helping manufacturers reduce dependency on single-source parts while maintaining quality, compliance and product performance. By agreeing suitable alternatives in advance, organisations can respond more effectively to supply chain disruptions and support the continued delivery of critical therapies.

Learn more about WMArchitect Interchangeable Parts